Mr. Speaker, could my colleague from Hochelaga perhaps elaborate on the negative effects that the comprehensive economic and trade agreement could have on pharmaceuticals and the cost of prescription drugs in Canada?
In the House of Commons on December 9th, 2016. See this statement in context.